Advertisement

Insulin Resistant Syndromes in Humans

  • Robert S. Bar
  • Michele Muggeo
  • Jesse Roth
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 124)

Abstract

Clinical states of insulin resistance are characterized by elevated circulating levels of insulin and resistance to the action of exogenous insulin (Berson and Yalow, 1970). In some states of insulin resistance, delivery of insulin to target tissues is impaired; however, in most, the delivery of insulin to its peripheral target tissues is normal and the resistance results from peripheral antagonism to the action of insulin. Several recent studies have examined the interaction of insulin with its target cell receptors in clinical conditions of diminished sensitivity to insulin (Bar and Roth, 1977; Kahn, Megyesi, Bar, Eastman, and Flier, 1977). These studies have demonstrated that both the concentration and the affinity of the insulin receptors undergo wide fluctuation under numerous biologically relevant conditions. Several conditions were characterized by decreases in the concentration of receptors, with the decrease in receptor concentration related to the severity of the insulin resistance. In other conditions, changes in receptor affinity were predominant and were unrelated to the environmental insulin concentration. Taken together, these studies indicate that the insulin receptor is a major site for the regulation of target cell responsiveness in vivo.

Keywords

Insulin Resistance Obese Patient Insulin Receptor Plasma Insulin Level Insulin Binding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bar, R. S., Gorden, P., Roth J., Kahn, C.R., and De Meyts, P. 1976. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients. J. Clin. Invest. 58:1123–1135.PubMedCrossRefGoogle Scholar
  2. Bar, R.S. and Roth, J, 1977. Insulin receptor status in disease states of man. Arch. Int. Med. 137:474–481.CrossRefGoogle Scholar
  3. Bender, A.N., Rengel, S.P., Engle, W.K., Daniels, M.P., and Vogel, Z. 1975. Myasthenia gravis: A serum factor blocking acetylcholine receptors of the human neuromuscular function. Lancet 1:607–609.PubMedCrossRefGoogle Scholar
  4. Berson, S.A. and Yalow, R.S. 1970. Insulin “antagonists” and insulin resistance, p. 389. IN M. Ellenberg and H. Rifkin (Eds.) Diabetes mellitus: Theory and -practice. New York: McGraw-Hill.Google Scholar
  5. De Meyts, P. and Roth, J. 1975. Cooperativity in ligand binding. A new graphic analysis. Biochem. Biophys. Res. Commun. 66: 1118–1126.PubMedCrossRefGoogle Scholar
  6. Desbuquois, B. and Cuatrecasas, P. 1973. Insulin receptors. Ann. Rev. Med. 24:233–240.PubMedCrossRefGoogle Scholar
  7. Field, J.B., Johnson, P., and Herring, B. 1961. Insulin-resistant diabetes associated with increased endogenous plasma insulin followed by complete remission. J. Clin. Invest. 40: 1672–1683.PubMedCrossRefGoogle Scholar
  8. Flier, J.S., Kahn, C.R., Roth, J., and Bar, R.S. 1975. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190:63–65.PubMedCrossRefGoogle Scholar
  9. Gavin, J.R. III, Roth, J., Neville, D.M., Jr., De Meyts, P., and Buell, D.M. 1974. Insulin-dependent regulation of insulin receptor concentrations. A direct demonstration in cell culture. Proc. Natl. Acad. Sci. USA 71:84–88.PubMedCrossRefGoogle Scholar
  10. Harrison, L.C., Martin, F.I.R., and Melick, R.A. 1976. Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects. J. Clin. Invest. 58:1435–1441.PubMedCrossRefGoogle Scholar
  11. Kahn, C.R., Flier, J. S., Bar, R.S., Archer, J. A., Gorden, P., Martin, M., and Roth, J. 1976. The syndromes of insulin resistance and acanthosis nigricans. N. Eng. J. Med. 294: 739–745.CrossRefGoogle Scholar
  12. Kahn, C.R., Megyesi, K., Bar, R.S., Eastman, R.C., and Flier, J.S. 1977. Receptors for peptide hormones. Ann. Int. Med. 86:205–219.PubMedGoogle Scholar
  13. Rabinowitz, D. 1970. Some endocrine and metabolic aspects of obesity. Ann. Rev. Med. 21:241–258.PubMedCrossRefGoogle Scholar
  14. Rabinowitz, D. and Zierler, K.L. 1961. Forearm metabolism in obesity and its response to intra-arterial insulin. Lancet 2:690–692.PubMedCrossRefGoogle Scholar
  15. Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51:660–672.CrossRefGoogle Scholar
  16. Smith, B.R. 1974. Thyroid-stimulating immunoglobulins in Graves’ disease. Lancet 2:427–431.PubMedCrossRefGoogle Scholar
  17. Soll, A.H., Kahn, C.R., Neville, D.M., Jr., and Roth, J. 1975. Insulin receptor deficiency in genetic and acquired obesity. J. Clin. Invest. 56:769–780.CrossRefGoogle Scholar
  18. Bar, R.S., Flier, J.S., and Jarrett, D.B. 1977. Hypoglycemia and proliferation of low affinity insulin receptors in a patient with anti-receptor antibodies. Diabetes 26:354. (Abstr.)Google Scholar

Discussion References

  1. Bar, R.S., Harrison, L.C., Muggeo, M.M., Gordon, P., Kahn, C.R., and Roth, J. 1979. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv. Intern. Med. (in press).Google Scholar
  2. Flier, J.S., Bar, R.S., Muggeo, M.M., Kahn, C.R., Roth, J., and Gorden, P. 1978. The evolving course of patients with insulin receptor autoantibodies: Spontaneous remission or receptor proliferation with hypoglycemia. J. Clin. Endocrin. Metab. 47:985–995.CrossRefGoogle Scholar
  3. Kahn, C.R., Baird, K., Flier, J.S., and Jarrett, D.B. 1977. Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action. J. Clin. Invest. 60:1094–1106.PubMedCrossRefGoogle Scholar
  4. Kono, T. and Barham, F.W. 1971. The relationship between the insulin binding capacity of fat cells and the cellular response to insulin. Studies with intact and trypsin-treated fat cells. J. Biol. Chem. 246:6210–6216.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • Robert S. Bar
    • 1
    • 2
  • Michele Muggeo
    • 1
    • 2
  • Jesse Roth
    • 1
    • 2
  1. 1.Division of Endocrinology and MetabolismUniversity of IowaIowa CityUSA
  2. 2.Diabetes BranchNIAMDD; NIHBethesdaUSA

Personalised recommendations